Literature DB >> 23730910

Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists.

Steven R LaPlante1, Rebekah Carson, James Gillard, Norman Aubry, René Coulombe, Sylvain Bordeleau, Pierre Bonneau, Michael Little, Jeff O'Meara, Pierre L Beaulieu.   

Abstract

The pharmaceutical industry has recognized that many drug-like molecules can self-aggregate in aqueous media and have physicochemical properties that skew experimental results and decisions. Herein, we introduce the use of a simple NMR strategy for detecting the formation of aggregates using dilution experiments that can be performed on equipment prevalent in most synthetic chemistry departments. We show that (1)H NMR resonances are sensitive to large molecular-size entities and to smaller multimers and mixtures of species. Practical details are provided for sample preparation and for determining the concentrations of single molecule, aggregate entities, and precipitate. The critical concentrations above which aggregation begins can be found and were corroborated by comparisons with light scattering techniques. Disaggregation can also be monitored using detergents. This NMR assay should serve as a practical and readily available tool for medicinal chemists to better characterize how their compounds behave in aqueous media and influence drug design decisions.

Mesh:

Substances:

Year:  2013        PMID: 23730910     DOI: 10.1021/jm400535b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

Review 1.  Histone-modifying enzymes, histone modifications and histone chaperones in nucleosome assembly: Lessons learned from Rtt109 histone acetyltransferases.

Authors:  Jayme L Dahlin; Xiaoyue Chen; Michael A Walters; Zhiguo Zhang
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-11-03       Impact factor: 8.250

2.  Ionic liquid versus prodrug strategy to address formulation challenges.

Authors:  Anja Balk; Toni Widmer; Johannes Wiest; Heike Bruhn; Jens-Christoph Rybak; Philipp Matthes; Klaus Müller-Buschbaum; Anastasios Sakalis; Tessa Lühmann; Jörg Berghausen; Ulrike Holzgrabe; Bruno Galli; Lorenz Meinel
Journal:  Pharm Res       Date:  2014-12-23       Impact factor: 4.200

3.  Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.

Authors:  Rayyan Alam; Allen T Barbarovich; Wagma Caravan; Mirna Ismail; Angela Barskaya; David W Parkin; Brian J Stockman
Journal:  Chem Biol Drug Des       Date:  2018-06-19       Impact factor: 2.817

4.  Mechanisms of Specific versus Nonspecific Interactions of Aggregation-Prone Inhibitors and Attenuators.

Authors:  Stephen Boulton; Rajeevan Selvaratnam; Rashik Ahmed; Katherine Van; Xiaodong Cheng; Giuseppe Melacini
Journal:  J Med Chem       Date:  2019-05-10       Impact factor: 7.446

5.  Fungicidal amphotericin B sponges are assemblies of staggered asymmetric homodimers encasing large void volumes.

Authors:  Agnieszka Lewandowska; Corinne P Soutar; Alexander I Greenwood; Evgeny Nimerovsky; Ashley M De Lio; Jordan T Holler; Grant S Hisao; Anuj Khandelwal; Jiabao Zhang; Anna M SantaMaria; Charles D Schwieters; Taras V Pogorelov; Martin D Burke; Chad M Rienstra
Journal:  Nat Struct Mol Biol       Date:  2021-12-09       Impact factor: 18.361

6.  Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.

Authors:  Samantha N Muellers; Juliana A Gonzalez; Abinash Kaur; Vital Sapojnikov; Annie Laurie Benzie; Dean G Brown; David W Parkin; Brian J Stockman
Journal:  ACS Infect Dis       Date:  2019-02-01       Impact factor: 5.084

Review 7.  The essential roles of chemistry in high-throughput screening triage.

Authors:  Jayme L Dahlin; Michael A Walters
Journal:  Future Med Chem       Date:  2014-07       Impact factor: 3.808

8.  Colloidal aggregation: from screening nuisance to formulation nuance.

Authors:  Ahil N Ganesh; Eric N Donders; Brian K Shoichet; Molly S Shoichet
Journal:  Nano Today       Date:  2018-03-10       Impact factor: 20.722

9.  PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.

Authors:  Hamid R Nasiri; Philipp Mracek; Steffen K Grimm; Janine Gastaldello; Adrian Kolodzik; Dirk Ullmann
Journal:  Medchemcomm       Date:  2017-04-07       Impact factor: 3.597

10.  Suppression of problematic compound oligomerization by cosolubilization of nondetergent sulfobetaines.

Authors:  Yumiko Mizukoshi; Koh Takeuchi; Misa Arutaki; Takeshi Takizawa; Hiroyuki Hanzawa; Hideo Takahashi; Ichio Shimada
Journal:  ChemMedChem       Date:  2015-03-11       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.